Old Web
English
Sign In
Acemap
>
authorDetail
>
Jane Shi
Jane Shi
Hoffmann-La Roche
Oncology
Internal medicine
Medicine
Pathology
Cancer immunotherapy
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase Ib/II umbrella trial to evaluate the safety and efficacy of multiple 2L cancer immunotherapy (CIT) combinations in advanced/metastatic urothelial carcinoma (mUC): MORPHEUS-mUC.
2020
Journal of Clinical Oncology
Alexandra Drakaki
Arash Rezazadeh Kalebasty
Jae Lyun Lee
Juan Martin-Liberal
Miso Kim
Sang Joon Shin
Jane Shi
Sanjeev Mariathasan
Bo Ci
Viraj Degaonkar
Patrick Williams
Edward Cha
Julia D. Maltzman
Thomas Powles
Show All
Source
Cite
Save
Citations (2)
Pan-cancer population pharmacokinetics and exposure-safety and -efficacy analyses of atezolizumab in patients with high tumor mutational burden.
2020
Pharmacology Research & Perspectives
Colby S. Shemesh
Phyllis Chan
Fatema A. Legrand
David S. Shames
Meghna Das Thakur
Jane Shi
Lorna Bailey
Shweta Vadhavkar
Xian He
Wei Zhang
Rene Bruno
Show All
Source
Cite
Save
Citations (1)
1